1-9 of 9
Adam S. Kittai
Close
Sort by
Journal Articles

Postinfusion PD-1 + CD8 + CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma

Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert M. Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro Bezerra, Narendranath Epperla, Timothy J. Voorhees, Jonathan Brammer, Adam S. Kittai, David A. Bond, Yazeed Sawalha, Audrey Sigmund, John C. Reneau, Mark P. Rubinstein, Walter Hanel, Beth Christian, Robert A. Baiocchi, Kami Maddocks, Lapo Alinari, Sumithira Vasu, Marcos de Lima, Dongjun Chung, Samantha Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3140–3153.
https://doi.org/10.1182/bloodadvances.2023012073
Published: 2024
Includes: Supplemental data
Journal Articles

An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL

Clinical Trials & Observations
Adam S. Kittai, John N. Allan, Dan James, Helen Bridge, Miguel Miranda, Alan S. M. Yong, Fady Fam, Jack Roos, Vikram Shetty, Alan Skarbnik, Matthew S. Davids
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2861–2869.
https://doi.org/10.1182/bloodadvances.2023012142
Published: 2024
Includes: Supplemental data
Journal Articles

Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization

Samantha M. Teierle, Ying Huang, Adam S. Kittai, Seema A. Bhat, Michael Grever, Kerry A. Rogers, Weiqiang Zhao, Daniel Jones, John C. Byrd, Matthew R. Avenarius, Nyla A. Heerema, Jennifer A. Woyach, Cecelia R. Miller
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7239–7242.
https://doi.org/10.1182/bloodadvances.2023010753
Published: 2023
Includes: Supplemental data
Journal Articles

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Geoffrey Shouse, Andy Kaempf, Max J. Gordon, Andy Artz, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey A. Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S. Kittai, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3516–3529.
https://doi.org/10.1182/bloodadvances.2022009309
Published: 2023
Includes: Supplemental data
Journal Articles

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL

Clinical Trials & Observations
Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B. Cohen, Tamara K. Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason Romancik, Rahul S. Bhansali, Elyse I. Harris, Mckenzie Sorrell, Rebecca Masel, Adam S. Kittai, Nathan Denlinger, Audrey M. Sigmund, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane Winter, Barbara Pro, Leo I. Gordon, Alexey Danilov, Deborah Stephens, Nirav N. Shah, Vaishalee Kenkre, Stefan K. Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2657–2669.
https://doi.org/10.1182/bloodadvances.2022008240
Published: 2023
Includes: Supplemental data
Journal Articles

Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019

Adam S. Kittai, Ying Huang, Seema A. Bhat, Electra D. Paskett, Kerry A. Rogers, Jacqueline C. Barrientos, James L. Fisher, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2575–2579.
https://doi.org/10.1182/bloodadvances.2022008643
Published: 2023
Journal Articles

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy

Max Yano, Chia Sharpe, J. Rachel Lance, Janani Ravikrishnan, Kevan Zapolnik, Xiaokui Mo, Jennifer A. Woyach, Deepa Sampath, Adam S. Kittai, Sumithira Vasu, Seema Bhat, Kerry A. Rogers, Dean A. Lee, Natarajan Muthusamy, John C. Byrd
Journal: Blood Advances
Blood Adv (2022) 6 (20): 5641–5654.
https://doi.org/10.1182/bloodadvances.2021005883
Published: 2022
Includes: Supplemental data
Journal Articles

Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes

Clinical Trials & Observations
Jonathan M. Hyak, Ying Huang, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, John C. Byrd, Adam S. Kittai, Dan Jones, Cecelia R. Miller, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5124–5127.
https://doi.org/10.1182/bloodadvances.2022007708
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Clinical Trials & Observations
Adam S. Kittai, David A. Bond, Basem William, Ayman Saad, Sam Penza, Yvonne Efebera, Karilyn Larkin, Sarah A. Wall, Hannah K. Choe, Bhavana Bhatnagar, Sumithira Vasu, Jonathan Brammer, Polina Shindiapina, Meixiao Long, Alice Mims, Lynn O’Donnell, Seema A. Bhat, Kerry A. Rogers, Jennifer A. Woyach, John C. Byrd, Samantha M. Jaglowski
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4648–4652.
https://doi.org/10.1182/bloodadvances.2020002783
Published: 2020